Page last updated: 2024-08-26

diosgenin and angiotensin ii

diosgenin has been researched along with angiotensin ii in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Yu, XF; Zhou, GM; Zhou, HT1
Chen, L; Lei, L; Li, Q; Li, T1
Jiang, W; Lei, L; Li, Q; Ni, Y; Wan, Z; Wei, J1

Other Studies

3 other study(ies) available for diosgenin and angiotensin ii

ArticleYear
Diosgenin inhibits angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts through regulating the TGF‑β1/Smad3 signaling pathway.
    Molecular medicine reports, 2017, Volume: 15, Issue:5

    Topics: Actins; Angiotensin II; Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen Type I; Diosgenin; Extracellular Matrix; Fibroblasts; Fibronectins; Myocardium; Phosphorylation; Rats; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1

2017
Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways.
    Life sciences, 2018, Sep-15, Volume: 209

    Topics: Angiotensin II; Animals; Cardiomegaly; Diosgenin; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Vasoconstrictor Agents

2018
Polyphyllin I attenuates pressure over-load induced cardiac hypertrophy via inhibition of Wnt/β-catenin signaling pathway.
    Life sciences, 2020, Jul-01, Volume: 252

    Topics: Angiotensin II; Animals; Cardiomegaly; Diosgenin; Disease Models, Animal; Echocardiography; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Wnt Signaling Pathway

2020